Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jhanelle, Gray"'
Autor:
Joseph Markowitz, Anders Berglund, Saurabh Garg, Eric Welsh, Bin Fang, Yuliana Hernandez, Trevor Rose, Jhanelle Gray, John Koomen, James Mule
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/15d27429e07748538fa6e96c868abedb
Autor:
Laura Oswald, L Robert Gore, Melanie Buhlmann, Naomi Brownstein, Kea Turner, Andreas Saltos, Jhanelle Gray, Shirish Gadgeel, Clement Gwede, Susan Vadaparampil, Brian Gonzalez, Heather Jim
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Sandhya Prabhakaran, Chandler Gatenbee, Mark Robertson-Tessi, Amer A. Beg, Jhanelle Gray, Scott Antonia, Robert A. Gatenby, Alexander R. A. Anderson
1.AbstractLung cancer is the leading cause of cancer death worldwide with 1.76 million people die as a result of the disease yearly. Analyzing high-throughput multiplexed images of tissues has recently emerged as a routine clinical procedure for earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15e79c91f25a0d234736858c2fedcff1
https://doi.org/10.1101/2022.10.22.513219
https://doi.org/10.1101/2022.10.22.513219
Autor:
Marcelo V. Negrao, Haniel A. Araujo, Giuseppe Lamberti, Alissa J. Cooper, Teng Zhou, Neal Akhave, Lukas Delasos, J Kevin Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V. Aredo, Michael J. Dennis, Turja Chakrabarti, Susan Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, So Yeon Kim, Sarah Goldberg, Ying Ni, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Dwight Owen, Collin Blakely, Giannis Mountzios, Catherine A. Shu, Christine Bestvina, Marina Garassino, Kristen Marrone, Jhanelle Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Jurgen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlesi, Pradnya Patil, Don L. Gibbons, Funda Meric-Bernstam, J Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis
Publikováno v:
Cancer Research. 83:3431-3431
Background: Irreversible allosteric KRAS p.G12C inhibitors (KG12Ci) such as sotorasib and adagrasib have revolutionized the therapeutic landscape of advanced KG12C-mutant NSCLC, however individual responses are heterogeneous and curtailed by innate a
Autor:
Rafael Ramon Bravo, Mark Robertson-Tessi, Alexander R. Anderson, Robert Gatenby, Scott Antonia, Jhanelle Gray, Amer Beg, Matthew Schabath
Publikováno v:
Cancer Research. 83:853-853
We developed a novel modeling paradigm to specifically recapitulate 3D tissue at the resolution of CT imaging and yet capture single cell information: the population-based model (PBM). This PBM method allowed us to seed a model with individual cells
Autor:
Dung-Tsa Chen, Jhanelle Gray, Andreas Saltos, Trevor A Rose, Alberto Chiappori, Zachary Thompson, Ram Thapa
Publikováno v:
Cancer Research. 83:987-987
Purpose: Adverse event (AE) is a critical element in clinical trial to evaluate patient safety profile of the drug for benefit-risk assessment. AE is also shown to have clinical association. However, due to its complexity, utilization of AE data has
Autor:
Yolanda Pina, Ann Chen, John A Arrington, Rob Macaulay, Nam Tran, James Liu, Sepideh Mokhtari, Jiannong Li, Vincent Law, Solmaz Sahebjam, Kamran Ahmed, Ben Creelan, Jhanelle Gray, Gerald Wallace, Brittany Evernden, Christine L Stewart, Nikhil Khushalani, Inna Smalley, Keiran Smalley, Michael Vogelbaum, Michael Yu, Peter Forsyth
Publikováno v:
Neuro-Oncology. 24:vii59-vii59
BACKGROUND LMD from systemic cancer has a dismal prognosis with median survivals of 8-10 weeks. A phase 2 trial of PD-1 inhibitor monotherapy in LMD showed median overall survival (OS) of 3.6 months (Brastianos P et al., 2020). We determined the safe
Autor:
Andreas N. Saltos, Benjamin C. Creelan, Tawee Tanvetyanon, Alberto A. Chiappori, Scott J. Antonia, Michael R. Shafique, Milijana Ugrenovic-Petrovic, Samer Sansil, Anthony M. Neuger, Jongphil Kim, Eric Haura, Jhanelle Gray
Publikováno v:
Cancer Research. 82:CT515-CT515
Purpose: Oncogenic driver mutations in either KRAS or EGFR are present in up to 40-50% of NSCLC, share activation of the MAPK/ERK pathway and may be amenable to combination therapy to prevent negative feedback activation. In a phase I/IB trial, we te
Autor:
Sandhya Prabhakaran, Chandler Gatenbee, Mark Robertson-Tessi, Amer A. Beg, Jhanelle Gray, Scott Antonia, Robert A. Gatenby, Alexander R. Anderson
Publikováno v:
Cancer Research. 82:5037-5037
Rationale: Examination of multiplexed images of tissues has recently emerged as a routine clinical procedure for cancer diagnosis and prognosis. The simultaneous detection of numerous biomarkers enables the interpretation of cellular states and the c
Autor:
Sandhya Prabhakaran, Chandler D. Gatenbee, Mark Robertson-Tessi, Jeffrey West, Amer Beg, Jhanelle Gray, Scott Antonia, Robert A. Gatenby, Alexander R.A. Anderson
Publikováno v:
SSRN Electronic Journal.